跳至主要内容
临床试验/NCT00567515
NCT00567515已完成2 期

Safety and Effectiveness of Left Atrial Appendage Occlusion

AtriCure, Inc.1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2007年9月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
41
试验地点
1
主要终点
Safety - Device related complications

研究概览

简要总结

This study is to evaluate acute and long-term safety and effectiveness of Left atrial appendage occlusion (LAA)with the AtriCure LAA Occlusion System. This device will be applied in patients with atrial fibrillation (AF), paroxysmal, persistent and permanent, undergoing cardiac surgery with a concomitant Maze/Ablation procedure.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Documented history (paroxysmal, persistent or permanent) of AF [one episode within the last 12 months of enrollment]
  • Elective Maze procedure
  • Suitable anatomy
  • Able and willing to sign informed consent
  • Age over 18 years

排除标准

  • Patient from Intensive Care Unit with either:
  • intra-venous catecholamines
  • cardiac index <1.8 l/min.
  • Reoperative Cardiac Surgery
  • Systemic or Inflammatory disease
  • Recent myocardial infarction (< 21 days)
  • History of pericarditis
  • Patient taking part in any other device or drug study
  • Patient with known sensitivity or allergy to any of the device components

结局指标

主要结局

Safety - Device related complications

时间窗: 30 days

Efficacy - Occlusion of the LAA

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Safety and Effectiveness of Left Atrial Appendage... | 临床试验